Levels of IL-6, IFN-γ, IP- 10 and sIL-2R correlated with the stage, initial general condition, minimal disseminated disease, ALK antibody titers and risk of relapse among ALK+ ALCL patients. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.